Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
27.45
+0.40 (1.48%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Neurogene Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
131
Market Cap
428.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 925.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 216.11M |
| Century Therapeutics | 109.16M |
| Assembly Biosciences | 72.30M |
| Invivyd | 53.43M |
| PureTech Health | 6.39M |
| Armata Pharmaceuticals | 4.90M |
NGNE News
- 23 hours ago - Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy - Business Wire
- 8 days ago - Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors - Business Wire
- 20 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates - Business Wire
- 5 weeks ago - Neurogene Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Neurogene to Participate in Stifel 2026 Virtual CNS Forum - Business Wire
- 7 weeks ago - Neurogene Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Neurogene Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts